ERBB2 and neoplasm: We injected 3 × 106 JIMT-1.ffLuc tumor cells s.c. on both flanks on day 0, and then a single i.v. dose of 2.5 × 106 HER2-CAR T cells on day 14 post-tumor cell injection.